[GENiusVac, a novel antitumor vaccine strategy based on allogeneic plasmacytoid dendritic cells]. / GENiusVac, une stratégie vaccinale antitumorale innovante basée sur des cellules dendritiques plasmocytoïdes allogéniques.
Rev Med Interne
; 32(5): 329-32, 2011 May.
Article
in Fr
| MEDLINE
| ID: mdl-21429635
Full text:
1
Collection:
01-internacional
Health context:
2_ODS3
Database:
MEDLINE
Main subject:
Dendritic Cells
/
Cancer Vaccines
/
Neoplasms
Limits:
Animals
/
Humans
Language:
Fr
Journal:
Rev Med Interne
Year:
2011
Document type:
Article